RxDoctor Payments Data

Elsia Yoo, DO

Family Medicine · Nashville, TNNPI 1629509443

Payments from drug & device makers

$2,687in general payments, 2019–2025

Across 134 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$612
  • AbbVie$425
  • Pfizer$368
  • AstraZeneca$338
  • Lilly USA, LLC$256
  • GSK$235
  • plus $454 from 12 others

What the payments were for

  • Food & beverage$2,687100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,687 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$84,264
Medicare patients
179
Services billed
2,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$53,160
RybelsusSemaglutide31$43,374
JanuviaSitagliptin Phosphate20$30,857
FarxigaDapagliflozin Propanediol32$30,149
JardianceEmpagliflozin23$29,684
MounjaroTirzepatide25$27,964
XareltoRivaroxaban29$27,501
OzempicSemaglutide14$22,141
TrulicityDulaglutide16$20,315
MyrbetriqMirabegron25$18,146
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$12,142
Breo ElliptaFluticasone/Vilanterol23$11,595
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,014
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$8,049
Incruse ElliptaUmeclidinium Bromide13$4,908

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$612$65,51545 claims
PfizerEliquis, Paxlovid$368$54,59061 claims
Lilly USA, LLCMounjaro, Trulicity$256$48,27941 claims
AstraZenecaFarxiga, Breztri Aerosphere$338$42,29150 claims
Boehringer IngelheimJardiance$23$29,68423 claims
Johnson & JohnsonXarelto$19$27,50129 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$235$26,51752 claims
Astellas Pharma US IncMyrbetriq$36$18,14625 claims
AbbVieSynthroid$425$89037 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →